To further understand the effect of SLC12A5 on tumour malignancy and find potential drugs for therapy, we predicted drug sensitivity of total 198 drugs in TCGA glioma cohorts based on ridge regression model taking GDSC data sets as training set. This evidence concerns the gene SLC12A5 and central nervous system cancer.